BWXT Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

Q4 Revenue: $886 million, up 19% year-over-year.
Full Year Revenue: Grew 18% to approximately $3.2 billion.
Adjusted EBITDA: $148 million for Q4, up 13% year-over-year; full year adjusted EBITDA grew 15%.
Earnings Per Share (EPS): Adjusted EPS of $1.08 for Q4, up 17%; full year EPS grew 20%.
Free Cash Flow: $57 million for Q4; $295 million for the full year, up 16%.
Backlog: Ended 2025 at $7.3 billion, a 50% increase year-over-year.

2. Strategic Updates and Business Highlights

Acquisitions: Successfully integrated AOT and Kinectrics, contributing to significant contracts including a $1.6 billion high-purity depleted uranium contract.
Facility Investments: Opened the BWST Innovation Campus and expanded the nuclear component plant in Cambridge, enhancing capacity for future demand.
Government Operations: Slight revenue decline of 1% in Q4, with focus on naval propulsion and new pricing agreements.
Commercial Operations: Impressive 31% organic revenue growth in Q4; total revenue growth of 95%, driven by strong performance in commercial nuclear power and medical sectors.
Microreactor and Advanced Nuclear Fuels: Delivered TRISO fuel for Project Pele and continued development in nuclear thermal propulsion with NASA.

3. Forward Guidance and Outlook

2026 Revenue Guidance: Expected to be approximately $3.75 billion, reflecting high teens growth compared to 2025.
Adjusted EBITDA Guidance: Anticipated between $645 million and $660 million, representing low to mid-teens growth.
EPS Guidance: Expected to be $4.55 to $4.70, driven by growth in both segments.
Free Cash Flow: Projected at $305 million to $320 million, supporting reinvestment and shareholder value creation.

4. Bad News, Challenges, or Points of Concern

Government Operations Margin Pressure: Expected to be slightly lower in 2026 due to new program contributions starting at lower profit recognition.
Seasonality Impact: Anticipated flat to slightly higher EBITDA in Q1 2026 due to seasonal effects and ramping of new programs.
Regulatory Uncertainty: Ongoing investigation by the Canadian Competition Bureau into the Kinectrics acquisition remains unresolved.
Tech 99 Approval Delays: No revenue from Tech 99 anticipated in 2026 guidance due to unresolved product quality issues.

5. Notable Q&A Insights

Government Operations Margins: CFO Mike Fitzgerald indicated that while 2026 may see some margin pressure, he expects a rebound in 2027.
AI Implementation: CEO Rex Geveden discussed the phased approach to AI integration, focusing on improving manufacturing processes and future factory automation.
Supply Chain Improvements: Positive developments in the shipbuilding supply chain were noted, with expectations for improved throughput.
M&A Strategy: BWXT remains open to M&A opportunities, focusing on core business expansion and capacity enhancement.
TRISO Fuel Market: Rex highlighted the growing demand for TRISO fuel in microreactor technologies and potential commercial applications.

Overall, BWXT reported strong financial performance in 2025, with significant growth across its segments, while also facing challenges related to margins and regulatory scrutiny. The company remains optimistic about its strategic initiatives and market opportunities moving forward.

BWXT — BWX Technologies, Inc.